<--- Back to Details
First PageDocument Content
Medicine / Pancreas disorders / Channelopathy / Cystic fibrosis / Sweat test / Immunoreactive trypsinogen / Mucus / Meconium / Ivacaftor / Health / Pediatrics / Biology
Date: 2012-02-06 15:23:13
Medicine
Pancreas disorders
Channelopathy
Cystic fibrosis
Sweat test
Immunoreactive trypsinogen
Mucus
Meconium
Ivacaftor
Health
Pediatrics
Biology

Newborn Screening for Biotinidase Deficiency

Add to Reading List

Source URL: www.kdheks.gov

Download Document from Source Website

File Size: 36,61 KB

Share Document on Facebook

Similar Documents

Cystic fibrosis / Cystic fibrosis transmembrane conductance regulator / CFTR / F508 / Ivacaftor / Epithelial sodium channel / S cell / Aggresome / Transfection / Sulfate permease

OPEN SUBJECT AREAS: FLUORESCENCE IMAGING DRUG DEVELOPMENT HIGH-THROUGHPUT SCREENING

DocID: 1pyUW - View Document

Pulmonary-Allergy Drugs Advisory Committee Meeting Lumacaftor/Ivacaftor Tablets for oral use NDAFDA Opening Remarks and Regulatory History

DocID: 1eMZq - View Document

FDA Advisory Committee Briefing Materials ORKAMBI™ (Lumacaftor/Ivacaftor) for CF Page 1 of 98 Sponsor Briefing Document

DocID: 1dX4Q - View Document

11. On page 120, the 3rd sentence in Section 2.5 should read “In my opinion, it would be a bad idea to conclude that ivacaftor was similar to placebo and even worse to conclude that LUM/IVA was better than placebo iv

DocID: 1aHHB - View Document

Ivacaftor / Phenols / Quinolones / Pharmaceutical Benefits Scheme / Cystic fibrosis / Vertex Pharmaceuticals / Clinical trial / Spirometry / Health / Medicine / Anilides

PDF Document

DocID: 17l0S - View Document